3 Reasons to Avoid DOX and 1 Stock to Buy Instead
Amdocs has been treading water for the past six months, recording a small return of 3.2% while holding steady at $89.48.
3 Reasons to Sell ZVIA and 1 Stock to Buy Instead
What a fantastic six months it’s been for Zevia. Shares of the company have skyrocketed 95.3%, hitting $2.09. This run-up might have investors contemplating their next move.
3 Reasons IEX is Risky and 1 Stock to Buy Instead
Over the past six months, IDEX’s shares (currently trading at $184.50) have posted a disappointing 13.2% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons UNF is Risky and 1 Stock to Buy Instead
UniFirst currently trades at $198 per share and has shown little upside over the past six months, posting a middling return of 4.4%.
3 Reasons to Sell OPEN and 1 Stock to Buy Instead
What a brutal six months it’s been for Opendoor. The stock has dropped 43.1% and now trades at $1.23, rattling many shareholders. This might have investors contemplating their next move.
3 Reasons to Sell IIIN and 1 Stock to Buy Instead
Over the past six months, Insteel’s stock price fell to $27.43. Shareholders have lost 12.7% of their capital, disappointing when considering the S&P 500 was flat. This may have investors wondering how to approach the situation.
3 Reasons VLTO is Risky and 1 Stock to Buy Instead
Over the past six months, Veralto’s shares (currently trading at $98) have posted a disappointing 12% loss while the S&P 500 was flat. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons HLT is Risky and 1 Stock to Buy Instead
Hilton currently trades at $231.61 per share and has shown little upside over the past six months, posting a middling return of 1.4%.
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and worst performers in the surgical equipment & consumables - diversified industry.
Automation Software Stocks Q4 Recap: Benchmarking Microsoft (NASDAQ:MSFT)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Microsoft (NASDAQ:MSFT) and the rest of the automation software stocks fared in Q4.
Popular Post
- Q4 Earnings Outperformers: Lincoln Educational (NASDAQ:LINC) And The Rest Of The Education Services Stocks Mar 12, 2025
- Asia Set for Cautious Start Into Jackson Hole Week: Markets Wrap Aug 18, 2024
- Sunrun, Sphere Entertainment, Installed Building Products, AMC Entertainment, and American Airlines Stocks Trade Down, What You Need To Know Apr 16, 2025